Related Experiment Videos
[Prevention and antibiotic treatment of Pseudomonas aeruginosa septicemia]
1Peking Union Medical College Hospital, Beijing.
Abstract:
Thirty-six cases of pseudomonas aeruginosa septicemia were found in 5 years from 1986 to 1990. The main risk factors predisposing septicemia included severe underlying diseases and local primary infection or impaired anatomic barrier. The use of broad-spectrum antibiotics, cytotoxic or immunosuppressive therapy, and leukopenia were also important risk factors. The percentages of in vitro resistant strains to 8 antipseudomonal antibiotics varied from 18% to 47%. The overall effective rate was 42% in 26 patients receiving appropriate antibiotic therapy. The mortality attributable to pseudomonas aeruginosa septicemia was 61%. The prevention and antibiotic treatment of pseudomonas aeruginosa septicemia are discussed.
Insights
Pseudomonas aeruginosa septicemia poses significant risks, especially in patients with severe illnesses or compromised barriers. High mortality rates underscore the need for effective prevention and antibiotic strategies against resistant strains.
Area of Science:
- Infectious Diseases
- Clinical Microbiology
- Critical Care Medicine
Background:
- Pseudomonas aeruginosa septicemia is a serious bloodstream infection.
- Identifying predisposing factors and antibiotic resistance patterns is crucial for patient outcomes.
Purpose of the Study:
- To analyze the incidence, risk factors, and outcomes of Pseudomonas aeruginosa septicemia.
- To evaluate the in vitro antibiotic resistance of Pseudomonas aeruginosa strains.
- To assess the effectiveness of antibiotic therapy and mortality rates.
Main Methods:
- Retrospective analysis of 36 cases of Pseudomonas aeruginosa septicemia from 1986 to 1990.
- Assessment of patient risk factors, including underlying diseases and immunosuppression.
- Evaluation of in vitro antibiotic susceptibility testing and treatment outcomes.
Main Results:
- Severe underlying diseases, local infections, impaired barriers, broad-spectrum antibiotics, and leukopenia were identified as key risk factors.
- In vitro resistance to 8 antipseudomonal antibiotics ranged from 18% to 47%.
- Appropriate antibiotic therapy yielded a 42% effective rate, with an overall attributable mortality of 61%.
Conclusions:
- Pseudomonas aeruginosa septicemia is associated with high mortality, particularly in vulnerable patients.
- Significant in vitro antibiotic resistance necessitates careful selection of antimicrobial agents.
- Effective prevention and timely, appropriate antibiotic treatment are critical for improving survival rates.